期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | BMC MEDICAL IMAGING LetPub Score 5.2
50 ratings
Rate
Reputation 5.9 Influence 3.8 Speed 8.8 | ||||||||||||||||
期刊簡稱 | BMC MED IMAGING | ||||||||||||||||
ISSN | 1471-2342 | ||||||||||||||||
h-index | 31 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/journal/12880 | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/BMIM | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||
主題領域 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 2001 | ||||||||||||||||
每年文章數 | 213每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 99.84% | ||||||||||||||||
OA Related Info | APC: Yes( GBP2190; USD2990; EUR2490; ) APC waiver:Check Notes Other charges: No Keywords: medical imaging、image processing、imaging techniques Useful LinksAims & ScopeAuthor InstructionsEditorial BoardOpen peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1471-2342%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 27 Weeks | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[BMC MEDICAL IMAGING] 的評論 | 撰寫評論 |
作者: 万花成娟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-26 20:18:28 評論於 How long will it take to make the changes?(0) 讚! | 万花成娟 |
作者: 上清巧双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-18 08:45:45 評論於 Review speed: 1.0 Research focus: Image experience sharing Submitted on May 21, accepted on July 19, the only issue is the high cost, everything else is fine.(0) 讚! | 上清巧双 |
作者: 乌龙笑萱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-28 17:18:34 評論於 I initially invited 7 reviewers, but now it has turned into a technical review. What does this mean?(0) 讚! | 乌龙笑萱 |
作者: 碧波海云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-04 20:27:15 評論於 Did you win, bro?(0) 讚! | 碧波海云 |
作者: 碧波海云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-23 19:55:34 評論於 Nothing(0) 讚! | 碧波海云 |
作者: 暗月寺采萱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-02 16:51:12 評論於 I want to ask, I sent an email about a technical issue, but when I click on the webpage, I don't know where to make modifications. What should I do?(0) 讚! | 暗月寺采萱 |
作者: Anna Isabel 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-19 14:00:54 評論於 Review speed: 3.0 Experience sharing: There has only been one reviewer for the second review, rejection after more than two months, only one out of four reviewers rejected, the others all agreed(0) 讚! | Anna Isabel |
作者: Rock North 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-10 20:55:40 評論於 Are we allowed to recommend reviewers when submitting a manuscript?(0) 讚! | Rock North |
作者: 雅晗三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-09 12:24:10 評論於 Review speed: 6.0 | Submission hit rate: 50.0 Emphasis on research direction: Imaging; Emphasis on sharing clinical experience: Submitted on January 12, revised on March 23, under peer review on April 24, major revision on April 30, revised on May 10, minor revision on May 11. The revision process has been quite lengthy, currently still under technical review. Hopefully the outcome will be positive(0) 讚! | 雅晗三岁啦 |
作者: 仲夏雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-09 22:47:00 評論於 I am almost four months now and still no news(0) 讚! | 仲夏雨旋 |
作者: 红爱小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-11 14:42:37 評論於 Review speed: 6.0 | Submission hit rate: 5.0 Focus on research direction: Image experience sharing: It has been almost three months and there is still no news(0) 讚! | 红爱小娘子 |
作者: 红爱小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-15 08:36:00 評論於 Any news?(0) 讚! | 红爱小娘子 |
作者: Xanthe McDonald 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-28 14:44:35 評論於 How long have you been investing?(0) 讚! | Xanthe McDonald |
作者: 流影冷梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-19 13:18:44 評論於 Review speed: 6.0 | Submission acceptance rate: 25.0 Experience sharing: It's a long way off(0) 讚! | 流影冷梅 |
作者: 流影冷梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-19 12:00:45 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Experience sharing: Using the Springer Nature platform, initially 4 reviewers, then 8, now 10, and still no review feedback received(0) 讚! | 流影冷梅 |
作者: 西行寺含蓉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-06 10:12:35 評論於 Review speed: 2.0 | Submission acceptance rate: 75.0 Sharing experience: Submission in January will be published in May(0) 讚! | 西行寺含蓉 |
作者: 觅雁小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-03 08:35:41 評論於 Please translate the following paragraph into English and Japanese, and title them as ":" and ":"(0) 讚! | 觅雁小娘子 |
作者: 北陆萧曼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-09 21:37:51 評論於 Are you still accepting case reports now?(0) 讚! | 北陆萧曼 |
作者: 韩仙俊 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-03-04 19:46:15 評論於 Submitted at the end of August in the 21st year, the reviewing process came back at the end of December. It required major revisions once and was reviewed by 3-5 individuals. After the revisions were made, it was accepted at the end of February in the 22nd year. It might have been delayed due to the impact of the pandemic; the reviewing process was slow.(0) 讚! | 韩仙俊 |
作者: Orville Lincoln 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-04 14:42:10 評論於 Review Speed: 6.0 | Submission Acceptance Rate: 75.0 Emphasis in Research Area: Clinical Cardiovascular Direction Experience Sharing: The speed is relatively slow, submitted in August 2021, accepted by the end of February 2022, accepted after a major revision two months later, with 3-5 reviewers in the first review(0) 讚! | Orville Lincoln |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:47:52 評論於 Currently ORCID is optional, not mandatory. It is important to note that most publishers (including Elsevier, Wiley, Nature, Thomsen Reuters) now require all researchers associated with their publications to use an ORCID iD. 19. How to add ORCID ID if it is not provided when an article is published? ORCID stands for Open Researcher and Contributor ID. ORCID iD is a unique and persistent scholarly identity for authors, distinguishing them from other researchers and recording all of their relevant research activities. To add an ORCID iD after publication, you need to log into each author's account and link it in the account information settings(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:59:22 評論於 Manuscript of the article(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 22:34:17 評論於 Is it necessary to provide the ORCID ID of each author when submitting a manuscript?(0) 讚! | 龙鳞孝礼 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:23:26 評論於 What is MS?(0) 讚! | 魂魄彦露 |
作者: 重阳柔煦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-19 08:17:45 評論於 Is it so fast? I saw on the magazine's official website that the review comments are given in 39 days(0) 讚! | 重阳柔煦 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us